Mucinous differentiation (MD) as predictor of response in BRAF-V600E mutated metastatic colorectal cancer (mCRC) treated with BRAF inhibitors (BRAFi) combinations

被引：0
|
作者：
Ros Montana, F. J. [1 ]
Navarro, V. [2 ]
Comas, R. [2 ]
Landolfi, S. [3 ]
Ramirez, L. [4 ]
Palmer, H. G. [1 ]
Garcia Rodriguez, A. [1 ]
Saoudi Gonzalez, N. [1 ]
Baraibar Argota, I. [1 ]
Rodriguez Castells, M. [5 ]
Salva Ballabrera, F. [6 ]
Tabernero, J. [7 ]
Elez Fernandez, M. E. [1 ]
机构：
[1] Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain
[2] Vall dHebron Inst Oncol VHIO, Oncol Data Sci ODysSey Grp, Cellex Ctr, Barcelona, Spain
[3] Vall dHebron Univ Hosp, Dept Pathol, Barcelona, Spain
[4] Vall dHebron Inst Oncol VHIO, Stem Cells Lab, Cellex Ctr, Barcelona, Spain
[5] Vall dHebron Inst Oncol VHIO, Med Oncol Dept, Cellex Ctr, Barcelona, Spain
[6] Vall dHebron Univ Hosp, Med Oncol Gastrointestinal Unit, Barcelona, Spain
[7] Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1817
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
626P
引用
收藏
页码：S447 / S447
页数：1
相关论文
共 50 条
  • [1] Treatment of metastatic BRAF-V600E mutated colorectal Carcinoma
    Pamuk, Aylin
    Zander, Thomas
    Alakus, Hakan
    Bruns, Christiane
    ONKOLOGE, 2020, 26 (03): : 292 - 294
  • [2] Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments
    Ros, J.
    Matito, J.
    Villacampa, G.
    Comas, R.
    Garcia, A.
    Martini, G.
    Baraibar, I.
    Saoudi, N.
    Salva, F.
    Martin, A.
    Antista, M.
    Toledo, R.
    Martinelli, E.
    Pietrantonio, F.
    Boccaccino, A.
    Cremolini, C.
    Dientsmann, R.
    Tabernero, J.
    Vivancos, A.
    Elez, E.
    ANNALS OF ONCOLOGY, 2023, 34 (06) : 543 - 552
  • [3] BRAF V600E-mutated Colorectal Neuroendocrine Carcinoma Effectively Treated with a Chemotherapy Protocol for BRAF-mutated Metastatic Colorectal Cancer
    Owaki, Seira
    Mori, Yoshinori
    Nakai, Shunsuke
    Maeda, Hideki
    Imazu, Mitsuki
    Tomita, Yusaku
    Kanaiwa, Hiroki
    Yamaguchi, Ayana
    Kitagawa, Mika
    Hirano, Atsuyuki
    Kimura, Yoshihide
    Tsuchida, Kenji
    Kataoka, Hiromi
    INTERNAL MEDICINE, 2024, 63 (14) : 1995 - 1999
  • [4] Treatment of BRAF-V600E mutant metastatic colorectal cancer: new insights and biomarkers
    Ros, Javier
    Rodriguez-Castells, Marta
    Saoudi, Nadia
    Baraibar, Iosune
    Salva, Francesc
    Tabernero, Josep
    Elez, Elena
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (08) : 797 - 806
  • [5] Somatic BRAF-V600E mutations in familial colorectal cancer
    Vandrovcova, Jana
    Lagerstedt-Robinsson, Kristina
    Pahlman, Lars
    Lindblom, Annika
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (11) : 2270 - 2273
  • [6] Influence of sex on safety and efficacy in BRAF-V600E mutated metastatic colorectal cancer (mCRC) treated with encorafenib-cetuximab plus /-binimetinib (E-C plus /-B)
    Montana, F. J. Ros
    Navarro, V.
    Comas, R.
    Rodriguez, A. Garcia
    Gomez, D.
    Gonzalez, N. Saoudi
    Vicente, P.
    Cuadra, J. L.
    Paez, D.
    Alonso, V.
    Martinez, A. Hernandez
    Valbuena, D. E. Lopez
    Argota, I. Baraibar
    Ballabrera, F. Salva
    Tabernero, J.
    Fernandez, M. E. Elez
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S707 - S707
  • [7] Impact of synchronous vs metachronous primary tumor resection on prognosis of BRAF-V600E mutant metastatic colorectal cancer (mCRC).
    Ahmed, Arwa Isameldin
    Philips, William
    Marginean, Horia
    Asmis, Timothy R.
    Vickers, Michael M.
    Lo, Bryan
    Goodwin, Rachel Anne
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL)
  • [8] Targeting Secondary and Tertiary Resistance to BRAF Inhibition in BRAF V600E-Mutated Metastatic Colorectal Cancer
    Akhoundova, Dilara
    Pietge, Heike
    Hussung, Saskia
    Kiessling, Michael
    Britschgi, Christian
    Zoche, Martin
    Rechsteiner, Markus
    Weber, Achim
    Fritsch, Ralph M.
    JCO PRECISION ONCOLOGY, 2021, 5 : 1082 - 1087
  • [9] Clinical prognostic score of BRAF V600E mutated (BM) metastatic colorectal cancer (mCRC): Results from the "BRAF, BeCool" platform.
    Intini, Rossana
    Loupakis, Fotios
    Cremolini, Chiara
    Sartore-Bianchi, Andrea
    Pietrantonio, Filippo
    Pella, Nicoletta
    Santini, Daniele
    Rimassa, Lorenza
    Formica, Vincenzo
    Calvetti, Lorenzo
    Salvatore, Lisa
    Antonuzzo, Lorenzo
    De Luca, Emmanuele
    Morano, Federica
    Tosi, Federica
    Moretto, Roberto
    Fassan, Matteo
    De Maglio, Giovanna
    Zagonel, Vittorina
    Di Maio, Massimo
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [10] Survival of patients (pts) with BRAF V600E mutated metastatic colorectal cancer (mCRC) treated with systemic therapy in a real-world setting
    Gotz, Moritz
    Kasper, Stefan
    Paul, Andreas
    Markus, Peter
    Schumacher, Brigitte
    Albers, David
    Rosery, Vivian
    Laue, Katharina
    Zaun, Gregor
    Kostbade, Karina
    Pogorzelski, Michael
    Schmid, Kurt Werner
    Schildhaus, Hans-Ulrich
    Wiesweg, Marcel
    Schuler, Martin
    Virchow, Isabel
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 65 - 66
12345